ICOS Corporation based in the Seattle, WA area is a biopharmaceutical company dedicated to discovering and developing breakthrough, proprietary products with high commercial potential for the treatment of serious medical diseases.
We've spent more than a decade building a highly credible, committed research and development team. Today, with the availability of Cialis® in global markets, and with product candidates moving through the product pipeline, we are strategically poised to become a strong and successful commercial organization.
Research: ICOS strives for a steady progression of product candidates, and currently has multiple major research and preclinical programs in progress. The Company has continually grown its research capabilities in molecular, cellular and structural biology; high-throughput drug screening; medicinal chemistry and genomics. ICOS researchers apply an integrated scientific approach to target areas of expertise.
Development: ICOS' development team encompasses experts in all areas of commercialization, clinical trial design and management, regulatory affairs, manufacturing and other vital areas needed to advance product candidates in a quick and effective manner. Our team members are driven to move candidates aggressively through the clinical steps, motivated by the potential to benefit patients sooner from their actions.
